Lyophilized Self‑Growth Factor versus PRP Injection for Knee Osteoarthritis
Official title: Comparing the Efficacy of Lyophilized Self Growth Factor Versus Platelet-Rich Plasma(PRP) Injection for Knee Osteoarthritis: A Prospective, Double-Blind, Randomized Controlled Trial
Run by Tri-Service General Hospital (TSGH) · NCT06932614 · Data updated 2026-11-12
This trial tests whether a lyophilized self-growth factor injection works better than standard PRP or placebo at reducing pain and improving function in adults with mild-to-moderate knee osteoarthritis.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 20 Years to 80 Years |
| Sex | All |
| Enrollment | 90 (estimated) |
| Sponsor | Tri-Service General Hospital (TSGH) Academic / other |
| Locations | 1 site (Taipei) |
| Status | Recruiting |
| Started | August 1, 2025 |
| Main results expected | July 31, 2026 |
| Study ends | July 31, 2026 |
| Registry record updated | September 10, 2025 |
| Trial ID | NCT06932614 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 20–80 with unilateral or bilateral mild-to-moderate knee osteoarthritis (Kellgren-Lawrence grades 1–3), symptoms for more than three months, and a baseline VAS pain score above 4 who have not had recent intra-articular steroid or hyaluronic acid injections are ideal candidates.
✕Probably not a fit
Patients with severe (KL grade 4) knee OA, active systemic infection, certain blood or clotting disorders, recent intra-articular steroid/HA injections within six months, recent major knee surgery, or uncontrolled serious comorbidities are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adults with mild-to-moderate knee osteoarthritis and persistent symptoms are randomized in a double-blind design to receive intra-articular injections of lyophilized self-repair factor (SRF), conventional platelet-rich plasma (PRP), or placebo. SRF is produced with multi-step centrifugation and proprietary processing to concentrate platelets and growth factors, then lyophilized for administration, while PRP is prepared from the patient’s own blood using standard centrifugation. The trial compares pain scores, functional outcomes, and safety over scheduled follow-up visits to determine whether the enhanced SRF offers superior clinical benefit to PRP or placebo. Procedures include baseline imaging confirmation of Kellgren-Lawrence grade 1–3 OA and monitoring for adverse events after injection.
Why it matters
Potential benefit: If successful, this approach could offer a more effective, longer-lasting injection that reduces knee pain and improves mobility compared with standard PRP or placebo.
How similar studies have gone: PRP injections for knee osteoarthritis have produced mixed but sometimes favorable results in prior studies, while lyophilized or multi-step concentrated SRF formulations remain relatively novel and less well studied.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male or female, aged over 20 and under 80. * Consciousness clear and able to communicate. * Unilateral or bilateral osteoarthritis of the knee with symptoms lasting more than 3 months. * X-ray imaging shows mild to moderate knee osteoarthritis (Kellgren-Lawrence grades 1-3). * Knee joint pain with a Visual Analogue Scale (VAS) score greater than 4. Exclusion Criteria: * Severe knee osteoarthritis (Kellgren-Lawrence grade 4). * Currently systemic infection. * Received hyaluronic acid or corticosteroid intraarticular injections within the past six months, or received NSAIDs or oral corticosteroid treatment within 7 days prior to treatment. * The treated joint has undergone joint replacement surgery or major surgery. * Severe knee deformity or instability. * Known history of cancers, rheumatoid arthritis, platelet dysfunction, thrombocytopenia, hypofibrinogenemia, acute or chronic infectious diseases, chronic liver disease, or poorly controlled cardiovascular disease or diabetes. * Currently receiving anticoagulant therapy. * Long-term or excessive use of aspirin or vitamin E. * History of HIV/AIDS, syphilis, or other legally notifiable infectious diseases. * Pregnant or breastfeeding women, or women and men of childbearing potential who are unable to use effective contraception during the treatment period. * Deemed unsuitable for participation in the trial by the principal investigator. * Unable to sign the informed consent form.
Where it's running
-
No. 325, Sec. 2, Chenggong Rd., Neihu Dist.
Taipei, Taiwan Recruiting
Study contacts
- Study coordinator: Yu Chi Su,, MD
- Email: vickysu0110@gmail.com
- Phone: +886287923311
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Effects of virtual reality on walking in adults with knee osteoarthritis
This study tests how immersive virtual reality environments—designed to feel safe or to provoke fear—affect walking and worry about movement in adults 50 and older with knee osteoarthritis and in healthy peers.
-
Weekly berobenatide for knee osteoarthritis in adults who are overweight or obese
This study tests whether weekly berobenatide helps reduce knee pain and improve function, while also affecting body weight, in adults with knee osteoarthritis who are overweight or obese (with or without type 2 diabetes).
-
Autologous adipose-derived stem cell injections for knee osteoarthritis
We’re testing whether injecting a patient’s own fat-derived stem cells into the knee can help people with knee OA feel less pain and move better, compared with a standard hyaluronic acid treatment.
-
Preoperative Multimorbidity and Functional Recovery After Total Knee Arthroplasty
This study tests whether higher burden of preoperative multimorbidity affects functional recovery after knee replacement in adults with knee osteoarthritis.
-
Cartilage biomarker response to acute loading in knee OA by antiresorptive treatment status
Researchers will test whether a 30-minute treadmill walk changes cartilage biomarkers in postmenopausal women with knee osteoarthritis, comparing those on denosumab, bisphosphonates, and those not on antiresorptives.
-
Lysyl Enzymes in Knee Osteoarthritis
This study tests whether blood levels of lysyl hydroxylase and lysyl oxidase differ between people with knee osteoarthritis and healthy individuals.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.